Long-term Monitoring for 4.5 Years*†1
The LINQ II insertable cardiac monitoring (ICM) system is the world's most accurate ICM, now with BlueSync™ technology.2-5 LINQ II ICM features enhanced TruRhythm™ algorithms, remote programming, and 4.5† years of longevity.*1see more of the LINQ II ICM System
Long-term Monitoring up to 3 Years6
The Reveal LINQ™ insertable cardiac monitoring (ICM) system includes a monitor placed just under the skin that provides continuous heart monitoring for up to 3 years.6Read more about Reveal Linq
With mobile app optimization set to “off,” the battery is projected to last 4.5 years. With mobile app optimization set to “on,” the battery is projected to last 2.5 years. See patient manual for additional information.
LINQ II™ clinician manual. M974764A001.
Nölker G, Mayer J, Boldt LH, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophysiol. December 2016;27(12):1403-1410.
Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017.
BIOTRONIK BioMonitor 2 Technical Manual. 2017.
Pürerfellner H, Sanders P, Sarkar S, et al. Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors. Europace. November 1, 2018;20(FI_3):f321-f328.
Refer to the Reveal LINQ ICM clinician manual for usage parameters.